Among tumor-infiltrating T cells, CD8+ T cells play a central role in immunotherapy-induced tumor immunity therefore tumor immunity is one of the determinants of outcome and prognosis in cancer patients [35]. This evidence concerns the gene CD8A and neoplasm.